Federated Hermes’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$590K Sell
6,527
-1,825
-22% -$155K ﹤0.01% 1290
2026
Q1
$698K Buy
8,352
+1,423
+21% +$117K ﹤0.01% 1214
2025
Q4
$635K Sell
6,929
-796
-10% -$76.2K ﹤0.01% 1245
2025
Q3
$732K Sell
7,725
-1,658
-18% -$156K ﹤0.01% 1236
2025
Q2
$983K Sell
9,383
-373
-4% -$35.4K ﹤0.01% 1149
2025
Q1
$862K Buy
9,756
+1,547
+19% +$159K ﹤0.01% 1152
2024
Q4
$788K Sell
8,209
-936
-10% -$87.2K ﹤0.01% 1185
2024
Q3
$749K Sell
9,145
-1,711
-16% -$132K ﹤0.01% 1223
2024
Q2
$936K Sell
10,856
-381
-3% -$30.8K ﹤0.01% 1130
2024
Q1
$917K Sell
11,237
-1,098
-9% -$85.7K ﹤0.01% 1156
2023
Q4
$818K Sell
12,335
-1,130
-8% -$78.3K ﹤0.01% 1205
2023
Q3
$984K Sell
13,465
-1,079
-7% -$72.9K ﹤0.01% 1115
2023
Q2
$918K Sell
14,544
-260
-2% -$15.1K ﹤0.01% 1165
2023
Q1
$869K Sell
14,804
-130
-0.9% -$7.89K ﹤0.01% 1212
2022
Q4
$921K Sell
14,934
-993
-6% -$66.7K ﹤0.01% 1157
2022
Q3
$1.07M Buy
15,927
+907
+6% +$57.4K ﹤0.01% 1104
2022
Q2
$922K Sell
15,020
-396
-3% -$25.4K ﹤0.01% 1172
2022
Q1
$1.04M Sell
15,416
-511
-3% -$27.6K ﹤0.01% 1238
2021
Q4
$705K Sell
15,927
-116
-0.7% -$6.76K ﹤0.01% 1382
2021
Q3
$1.04M Buy
16,043
+87
+0.5% +$6.04K ﹤0.01% 1268
2021
Q2
$1.28M Sell
15,956
-625
-4% -$47.6K ﹤0.01% 1233
2021
Q1
$1.13M Buy
16,581
+3,909
+31% +$307K ﹤0.01% 1321
2020
Q4
$883K Sell
12,672
-4,885
-28% -$304K ﹤0.01% 1367
2020
Q3
$902K Sell
17,557
-221
-1% -$12.1K ﹤0.01% 1276
2020
Q2
$1.04M Sell
17,778
-1,158
-6% -$64K ﹤0.01% 1232
2020
Q1
$958K Sell
18,936
-2,128
-10% -$141K ﹤0.01% 1158
2019
Q4
$1.56M Sell
21,064
-1,634
-7% -$102K ﹤0.01% 1112
2019
Q3
$1.3M Buy
22,698
+814
+4% +$54K ﹤0.01% 1191
2019
Q2
$1.43M Sell
21,884
-36,694
-63% -$2.55M ﹤0.01% 1173
2019
Q1
$4.33M Sell
58,578
-109,939
-65% -$7.73M 0.01% 820
2018
Q4
$10.1M Sell
168,517
-75,142
-31% -$6.06M 0.03% 487
2018
Q3
$23M Buy
243,659
+80,324
+49% +$6.92M 0.05% 322
2018
Q2
$12.3M Buy
163,335
+18,494
+13% +$1.33M 0.04% 385
2018
Q1
$8.77M Buy
144,841
+93,167
+180% +$5.04M 0.03% 467
2017
Q4
$2.41M Buy
51,674
+22,000
+74% +$1.09M 0.01% 865
2017
Q3
$1.5M Buy
+29,674
New +$1.38M ﹤0.01% 1048
2016
Q4
Sell
-13,425
Closed -$508K 2135
2016
Q3
$508K Sell
13,425
-895,675
-99% -$28.4M ﹤0.01% 1273
2016
Q2
$27.6M Hold
909,100
0.08% 196
2016
Q1
$22.4M Hold
909,100
0.07% 246
2015
Q4
$22.8M Sell
909,100
-250,407
-22% -$7.69M 0.07% 254
2015
Q3
$34.3M Buy
1,159,507
+7,007
+0.6% +$220K 0.11% 190
2015
Q2
$36.9M Buy
1,152,500
+622,600
+117% +$16.7M 0.11% 205
2015
Q1
$13.2M Buy
529,900
+456,900
+626% +$9.91M 0.04% 394
2014
Q4
$1.86M Sell
73,000
-2,000
-3% -$43.4K 0.01% 984
2014
Q3
$1.37M Buy
+75,000
New +$1.44M ﹤0.01% 1092

Other funds holding HQY

Federated Hermes's HQY Position: Q2 2026 in Review

Federated Hermes reduced its HealthEquity (HQY) stake by 22% in Q2 2026, selling an estimated $155K and leaving 6,527 shares worth $590K. The position accounts for ﹤0.01% of the portfolio, ranked #1290.

Federated Hermes first reported a position in HQY in Q3 2014 and has held it in 45 quarters since. The position peaked at $36.9M in Q2 2015. 498 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Federated Hermes held 6,527 shares of HealthEquity worth $590K as of Q2 2026.
  • Federated Hermes sold 1,825 HealthEquity shares in Q2 2026, an estimated $155K.
  • HealthEquity made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1290 holding.
  • Federated Hermes first reported a position in HealthEquity in Q3 2014 and has held it in 45 quarters since.
  • Federated Hermes's HealthEquity position peaked at $36.9M in Q2 2015.
  • 498 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.